1)recombinant cell重组细胞
1.The asymmetric reduction of ethyl 4-chloroacetoacetate(COBE) to ethyl(R)-(+)-4-chloro-3-hydroxybutyrate((R)-CHBE) by therecombinant cells in an aqueous phase was investigated.将重组细胞用于催化4-氯乙酰乙酸乙酯不对称还原,合成出具有光学活性的(R)-(+)-4-氯-3-羟基丁酸乙酯。
2.The optimal reaction conditions for the synthesis of S-adenosylmethionine(SAM) by therecombinant cells were investigated.实验发现,用φ(甲苯)=2%的水溶液对重组细胞进行通透化处理后,能大幅提高SAM的产率。
2)in-vivo recombination细胞内重组
3)Recombinant CHO cells重组CHO细胞
1.Optimization of Manufacturing Process of Recombinant CHO Cell Hepatitis B Vaccine重组CHO细胞乙肝疫苗生产工艺的优化
2.Study on High-level Expression of Recombinant Hepatitis B Surface Antigen in CHO Cell;重组CHO细胞高效表达乙肝表面抗原的研究
3.Establishment and Characteristics of Recombinant CHO Cell Lines to Express Hepatitis B Surface Antigen Carrying Pre-S表达含前S的乙肝病毒表面抗原重组CHO细胞株的建立和特性检测
4.Purification and Activity of Recombinant Human IL-12(CHO Cells)重组人白细胞介素-12(CHO细胞)的纯化及其活性
5.Stable Expression of the Recombinant Human Membrane Form Klotho Protein in CHO Cells;重组人膜型Klotho蛋白在CHO细胞中的稳定表达
6.Pilot Production Procedure of Adsorbed Acellular DTP-Recombinant Hepatitis B(CHO Cells)Combined Vaccine吸附无细胞百白破-重组乙型肝炎(CHO细胞)联合疫苗的中试工艺
7.Expression of Recombinant sPDGFRα-Fc in CHO and Its Anti-proliferation Analysis在CHO细胞中表达重组sPDGFRα-Fc及其抑制细胞增殖的研究
8.The Influence of CpG-ODN on the Immune Effects of Hepatitis B(HB) DNAvaccine and Recombinant Hepatitis B Vaccine.;CpG对乙肝核酸疫苗及基因重组（CHO细胞）疫苗免疫效果的影响
9.Research on Efficacy and Experimental Ldentification Method for Recombinant Hepatitis B Vaccine (Cell of CHO);重组乙型肝炎疫苗（CHO细胞）效力、鉴别实验的方法研究
10.Stable expression of human opioid receptor-like 1 in Chinese hamster ovary cells人重组阿片受体样受体在CHO细胞稳定表达系统的建立
11.Generation of Several CHO Cell Lines Stably Expressing Bovine, Porcine and Chicken Beta Interferon and Evaluation of Their Bioactivity;重组牛、猪和鸡β干扰素在CHO细胞中的高效稳定表达及其生物学活性研究
12.Improvement of Anti-HBsAg Antibody Production in CHO Cell;抗HBsAg抗体在CHO细胞中表达量提高研究
13.The Chinese Hamster Ovary Cells Apoptosis Induced by X-ray Irradiation;电离辐射致中国仓鼠卵巢（CHO）细胞凋亡
14.Construction of CHO Cells Stably Expressing CCR5;CCR5稳定表达的CHO细胞的构建
15.Construction of CHO Cell Line Stably Expressing Mouse Lamada-Interferon稳定表达鼠IFN-λ的CHO细胞系建立
16.Expression of Full-length MBL Gene of Han Chinese in CHO Cells汉族人MBL全长基因在CHO细胞中的表达
17.Primarily Exploring on Serum-low Culture of Engineering Cells of CHOCHO工程细胞株低血清培养的初探
18.Stable Expression of Bovine Prion Protein in CHO/dhfr-cells牛朊蛋白在CHO/dhfr-细胞中的稳定表达
相关短句/例句
in-vivo recombination细胞内重组
3)Recombinant CHO cells重组CHO细胞
4)recombinant BHK cell重组BHK细胞
5)organ recombination细胞器重组
6)Recombinant cell line重组细胞株
延伸阅读
重组人粒细胞-巨噬细胞集落刺激因子重组人粒细胞-巨噬细胞集落刺激因子这是一种调节造血和白细胞功能所必需的清蛋白、可刺激粒细胞和巨噬细胞等白细胞的增殖、分化和活化作用、从而增强造血功能，还能增强中性粒细胞、嗜酸性粒细胞及单核细胞的多种功能，促使效应细胞吞噬和消灭癌细胞等免疫活动增强。适用于治疗和预防化学疗法所引起的白细胞减少症及骨髓功能衰竭病人的白细胞减少。对化疗病人应在化疗停止24小时后开始使用。剂量每日5～10μg/kg，持续7～10天，此后至少间隔48小时再进行下一疗程化疗，骨髓增生异常综合征(MDS)及再生障碍性贫血的应用剂量：每日3μg/kg，每日1次，然后根据白细胞增多效应再调节剂量，维持在所期望白细胞计数水平。用于骨髓移植的剂量：每日5～10μg/kg，静注，每日1次，持续致中性粒细胞计数＞1000/μl达3天以上。此药不良反应最常见为发热，可用扑热息痛缓解，其他较少见的反应有低血压、恶心、水肿、胸痛、骨痛、腹泻、以及过敏反应等。
